Pneumonia-induced sepsis in mice: Temporal study of inflammatory and cardiovascular parameters

International Journal of Experimental Pathology

Volumn 94, Issue 2, 2013, Pages 144-155

  Sordi, Regina ^a   Menezes de Lima, Octávio ^b   Della Justina, Ana M ^a   Rezende, Edir ^a   Assreuy, Jamil ^a  

^a FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

^b INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

Klebsiella pneumoniae; Mouse; Nitric oxide; NOS 2; Pneumonia; Sepsis

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; NEURONAL NITRIC OXIDE SYNTHASE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL LOAD; CARDIOVASCULAR PARAMETERS; CELL COUNT; CONTROLLED STUDY; CYTOKINE RELEASE; DISEASE SEVERITY; HYPOTENSION; INFLAMMATION; KLEBSIELLA PNEUMONIAE INFECTION; LEUKOPENIA; LUNG LAVAGE; MALE; MEAN ARTERIAL PRESSURE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEPSIS; SEPTIC SHOCK;

KLEBSIELLA PNEUMONIAE; MOUSE; NITRIC OXIDE; NOS-2; PNEUMONIA; SEPSIS;

ANIMALS; BACTERIAL LOAD; BRONCHOALVEOLAR LAVAGE FLUID; CYTOKINES; DISEASE MODELS, ANIMAL; HUMANS; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; LEUKOCYTES; LUNG; MALE; MICE; MYOCARDIUM; NITRATES; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; NITRITES; PNEUMONIA, BACTERIAL; SEPSIS; SPLEEN;

EID: 84875052402     PISSN: 09599673     EISSN: 13652613     Source Type: Journal    
DOI: 10.1111/iep.12016     Document Type: Article

References (47)

1. Al-Banna N.A., Junaid T.A., Mathew T.C., Raghupathy R., Albert M.J. (2008) Histopathological and ultrastructural studies of a mouse lung model of Campylobacter jejuni infection. J. Med. Microbiol. 57, 210-217.
2. Alberti C., Brun-Buisson C., Burchardi H. et al. (2002) Epidemiology of sepsis and infection in ICU patients from an international multicentre cohort study. Intensive Care Med. 28, 108-121.
3. Angus D.C., Linde-Zwirble W.T., Lidicker J., Clermont G., Carcillo J., Pinsky M.R. (2001) Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit. Care Med. 29, 1303-1310.
4. Assreuy J. (2006) Nitric oxide and cardiovascular dysfunction in sepsis. Endocr. Metab. Immune Disord. Drug Targets 6, 165-173.
5. Baron R.M., Baron M.J., Perrella M.A. (2006) Pathobiology of sepsis: are we still asking the same questions? Am. J. Respir. Cell Mol. Biol. 34, 129-134.
6. Beck M.A., Nelson H.K., Shi Q. et al. (2001) Selenium deficiency increases the pathology of an influenza virus infection. FASEB. J. 15, 1481-1483.
7. Bianchi M.E. (2007) DAMPs, PAMPs and alarmins: all we need to know about danger. J. Leukoc. Biol. 81, 1-5.
8. Bone R.C., Balk R.A., Fein A.M. et al. (1995) A second large controlled clinical study of E5, a monoclonal antibody to endotoxin: results of a prospective, multicenter, randomized, controlled trial The E5 Sepsis Study Group. Crit. Care Med. 23, 994-1006.
9. Brain J.D., Knudson D.E., Sorokin S.P., Davis M.A. (1976) Pulmonary distribution of particles given by intratracheal instillation or by aerosol inhalation. Environ. Res. 11, 13-33.
10. Buras J.A., Holzmann B., Sitkovsky M. (2005) Animal models of sepsis: setting the stage. Nat. Rev. Drug. Discov. 4, 854-865.
11. Cogen A.L., Moore T.A. (2009) Beta2-microglobulin-dependent bacterial clearance and survival during murine Klebsiella pneumoniae bacteremia. Infect. Immun. 77, 360-366.
12. Cohen J. (2002) The immunopathogenesis of sepsis. Nature 420, 885-891.
13. Davis K.A., Santaniello J.M., He L.K. et al. (2004) Burn injury and pulmonary sepsis: development of a clinically relevant model. J. Trauma 56, 272-278.
14. Deitch E.A. (1998) Animal models of sepsis and shock: a review and lessons learned. Shock 9, 1-11.
15. Eskandari M.K., Bolgos G., Miller C., Nguyen D.T., DeForge L.E., Remick D.G. (1992) Anti-tumor necrosis factor antibody therapy fails to prevent lethality after cecal ligation and puncture or endotoxemia. J. Immunol. 148, 2724-2730.
16. Fernandes D., Assreuy J. (2008) Nitric oxide and vascular reactivity in sepsis. Shock 30(Suppl 1), 10-13.
17. Fernandes D., Sordi R., Pacheco L.K. et al. (2009) Late, but not early, inhibition of soluble guanylate cyclase decreases mortality in a rat sepsis model. J. Pharmacol. Exp. Ther. 328, 991-999.
18. Fisher C.J. Jr, Agosti J.M., Opal S.M. et al. (1996) Treatment of septic shock with the tumor necrosis factor receptor:Fc fusion protein The Soluble TNF Receptor Sepsis Study Group. N. Engl. J. Med. 334, 1697-1702.
19. Gebska A., Olszanecki R., Korbut R. (2005) Endotoxaemia in rats: role of leukocyte sequestration in rapid pulmonary nitric oxide synthase-2 expression. J. Physiol. Pharmacol. 56, 299-311.
20. Greisman S.E., DuBuy J.B., Woodward C.L. (1979) Experimental gram-negative bacterial sepsis: prevention of mortality not preventable by antibiotics alone. Infect. Immun. 25, 538-557.
21. Hjoberg J., Shore S., Kobzik L. et al. (2004) Expression of nitric oxide synthase-2 in the lungs decreases airway resistance and responsiveness. J. Appl. Physiol. 97, 249-259.
22. Horton J.W., Maass D.L., White D.J., Minei J.P. (2007) Bactericidal/permeability increasing protein attenuates the myocardial inflammation/dysfunction that occurs with burn complicated by subsequent infection. J. Appl. Physiol. 103, 948-958.
23. Kan W., Zhao K.S., Jiang Y. et al. (2004) Lung, spleen, and kidney are the major places for inducible nitric oxide synthase expression in endotoxic shock: role of p38 mitogen-activated protein kinase in signal transduction of inducible nitric oxide synthase expression. Shock 21, 281-287.
24. Kieft H., Hoepelman A.I., Zhou W., Rozenberg-Arska M., Struyvenberg A., Verhoef J. (1993) The sepsis syndrome in a Dutch university hospital Clinical observations. Arch. Intern. Med. 153, 2241-2247.
25. Kumar V. & Chhibber S. (2011) Acute lung inflammation in Klebsiella pneumoniae B5055-induced pneumonia and sepsis in BALB/c mice: a comparative study. Inflammation 34, 452-462.
26. Lange M., Connelly R., Traber D.L. et al. (2010) Time course of nitric oxide synthases, nitrosative stress, and poly(ADP ribosylation) in an ovine sepsis model. Crit. Care 14, R129.
27. McCloskey R.V., Straube R.C., Sanders C., Smith S.M., Smith C.R. (1994) Treatment of septic shock with human monoclonal antibody HA-1A A randomized, double-blind, placebo-controlled trial. CHESS Trial Study Group. Ann. Intern. Med. 121, 1-5.
28. Mizgerd J.P. & Skerrett S.J. (2008) Animal models of human pneumonia. Am. J. Physiol. Lung Cell. Mol. Physiol. 294, L387-L398.
29. Moncada S., Palmer R.M., Higgs E.A. (1991) Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol. Rev. 43, 109-142.
30. Muenzer J.T., Davis C.G., Dunne B.S., Unsinger J., Dunne W.M., Hotchkiss R.S. (2006) Pneumonia after cecal ligation and puncture: a clinically relevant "two-hit" model of sepsis. Shock 26, 565-570.
31. O'Brien J.M. Jr, Ali N.A., Aberegg S.K., Abraham E. (2007). Sepsis. Am. J. Med. 120, 1012-1022.
32. Piper R.D., Cook D.J., Bone R.C., Sibbald W.J. (1996) Introducing Critical Appraisal to studies of animal models investigating novel therapies in sepsis. Crit. Care Med. 24, 2059-2070.
33. Poli-de-Figueiredo L.F., Garrido A.G., Nakagawa N., Sannomiya P. (2008) Experimental models of sepsis and their clinical relevance. Shock 30(Suppl 1), 53-59.
34. Preiser J.C., Zhang H., Vray B., Hrabak A., Vincent J.L. (2001) Time course of inducible nitric oxide synthase activity following endotoxin administration in dogs. Nitric Oxide 5, 208-211.
35. Schurr J.R., Young E., Byrne P., Steele C., Shellito J.E., Kolls J.K. (2005) Central role of toll-like receptor 4 signaling and host defense in experimental pneumonia caused by Gram-negative bacteria. Infect. Immun. 73, 532-545.
36. Soares A.C., Pinho V.S., Souza D.G. et al. (2002) Role of the platelet-activating factor (PAF) receptor during pulmonary infection with gram negative bacteria. Br. J. Pharmacol. 137, 621-628.
37. Sordi R., Fernandes D., Assreuy J. (2010) Differential involvement of potassium channel subtypes in early and late sepsis-induced hyporesponsiveness to vasoconstrictors. J. Cardiovasc. Pharmacol. 56, 184-189.
38. Sordi R., Fernandes D., Heckert B.T., Assreuy J. (2011) Early potassium channel blockade improves sepsis-induced organ damage and cardiovascular dysfunction. Br. J. Pharmacol. 163, 1289-1301.
39. Sunil V.R., Connor A.J., Guo Y., Laskin J.D., Laskin D.L. (2002) Activation of type II alveolar epithelial cells during acute endotoxemia. Am. J. Physiol. Lung Cell. Mol. Physiol. 282, L872-L880.
40. Sutherland R.E., Olsen J.S., McKinstry A., Villalta S.A., Wolters P.J. (2008) Mast cell IL-6 improves survival from Klebsiella pneumonia and sepsis by enhancing neutrophil killing. J. Immunol. 181, 5598-5605.
41. Szabó C. (1996) The pathophysiological role of peroxynitrite in shock, inflammation, and ischemia-reperfusion injury. Shock 6, 79-88.
42. Tsiotou A.G., Sakorafas G.H., Anagnostopoulos G., Bramis J. (2005) Septic shock; current pathogenetic concepts from a clinical perspective. Med. Sci. Monit. 11, RA76-RA85.
43. Walley K.R., Lukacs N.W., Standiford T.J., Strieter R.M., Kunkel S.L. (1996) Balance of inflammatory cytokines related to severity and mortality of murine sepsis. Infect. Immun. 64, 4733-4738.
44. Wang E., Ouellet N., Simard M. et al. (2001) Pulmonary and systemic host response to Streptococcus pneumoniae and Klebsiella pneumoniae bacteremia in normal and immunosuppressed mice. Infect. Immun. 69, 5294-5304.
45. Wicher K., Abbruscato F., Wicher V., Baughn R., Noordhoek G.T. (1996) Target organs of infection in guinea pigs with acquired congenital syphilis. Infect. Immun. 64, 3174-3179.
46. Wu F., Wilson J.X., Tyml K. (2003) Ascorbate inhibits iNOS expression and preserves vasoconstrictor responsiveness in skeletal muscle of septic mice. Am. J. Physiol. Regul. Integr. Comp. Physiol. 285, R50-R56.
47. Zhang Q., Raoof M., Chen Y. et al. (2010) Circulating mitochondrial DAMPs cause inflammatory responses to injury. Nature 464, 104-107.